(Q33801496)

29 July 2017

title

Proteomic studies coupled with RNAi methodologies can shed further light on the downstream effects of telomerase in glioma (English)

1 reference

29 July 2017

Dipti Thakkar

1

1 reference

29 July 2017

Leroy Shervington

series ordinal

2

1 reference

29 July 2017

Amal Shervington

series ordinal

3

1 reference

29 July 2017

publication date

1 February 2011

1 reference

29 July 2017

1 reference

29 July 2017

volume

29

1 reference

29 July 2017

issue

2

1 reference

29 July 2017

page(s)

113-122

1 reference

Molecularly targeted therapies for malignant gliomas.

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.543212

New therapeutic approach for brain tumors: Intranasal delivery of telomerase inhibitor GRN163

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.543212

Telomerase subunits expression variation between biopsy samples and cell lines derived from malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.543212

Hallmarks of telomeres in ageing research

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.543212

Human telomerase and its regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.543212

Glioma: what is the role of c-Myc, hsp90 and telomerase?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.543212

Can hsp90alpha-targeted siRNA combined with TMZ be a future therapy for glioma?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.543212

Proteomics: the tool to bridge the gap between the facts and fables of telomerase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.543212

Silencing DNA methyltransferase (DNMT) enhances glioma chemosensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.543212

The sensitization of glioma cells to cisplatin and tamoxifen by the use of catechin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.543212

Proteomic analysis of human bone marrow mesenchymal stem cells transduced with human telomerase reverse transcriptase gene during proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.543212

Prognostic significance of the 67-kilodalton laminin receptor expression in human breast carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.543212

Comparative analysis of annexin-1 in neuroepithelial tumors shows altered expression with the grade of malignancy but is not associated with survival

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.543212

Ran suppresses paclitaxel-induced apoptosis in human glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.543212

Multidrug-resistance-associated protein MGr1-Ag is identical to the human 37-kDa laminin receptor precursor.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.543212

Increased expression of annexin I and thioredoxin detected by two-dimensional gel electrophoresis of drug resistant human stomach cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.543212

Use of comparative proteomics to identify potential resistance mechanisms in cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.543212

The small nuclear GTPase Ran: how much does it run?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.543212

The great escape: when cancer cells hijack the genes for chemotaxis and motility

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.543212

Diphosphorylated MRLC is required for organization of stress fibers in interphase cells and the contractile ring in dividing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.543212

Dependence of metastatic cancer cell invasion on MLCK-catalyzed phosphorylation of myosin regulatory light chain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.543212

Cancer cell motility--on the road from c-erbB-2 receptor steered signaling to actin reorganization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.543212

Regulation of the actin cytoskeleton in cancer cell migration and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.543212

Purification and characterization of beta-actin-rich tumor cell pseudopodia: role of glycolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.543212

Cyclophilins and their possible role in the stress response

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.543212

A serine/arginine-rich nuclear matrix cyclophilin interacts with the C-terminal domain of RNA polymerase II

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.543212

Unique proteomic features induced by a potential antiglioma agent, Nordy (dl-nordihydroguaiaretic acid), in glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.543212

Domain- and sequence-specific phosphorylation of vimentin induces disassembly of the filament structure.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.543212

Mechanotransduction Across the Cell Surface and Through the Cytoskeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.543212

Modulation of IMPDH2, survivin, topoisomerase I and vimentin increases sensitivity to methotrexate in HT29 human colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.543212

Is current therapy of malignant gliomas beneficial for patients? Proteomics evidence of shifts in glioma cells expression patterns under clinically relevant treatment conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.543212

Up-regulation of vimentin expression in low-density malignant glioma cells as immediate and late effects under irradiation and temozolomide treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.543212

10.3109/07357907.2010.543212

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference